167 related articles for article (PubMed ID: 27692813)
1. Prolonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation: A Case Report.
Msaouel P; Zhang M; Tu SM
Clin Genitourin Cancer; 2017 Feb; 15(1):e73-e77. PubMed ID: 27692813
[No Abstract] [Full Text] [Related]
2. Pegylated Liposomal Doxorubicin Is an Active Agent for Chemotherapy-Resistant Choriocarcinoma: A Report of Two Cases.
Popadiuk C; Power P
J Reprod Med; 2016; 61(5-6):215-8. PubMed ID: 27424361
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy for elderly patients with lung cancer].
Okamoto H; Watanabe K
Nihon Rinsho; 2002 May; 60 Suppl 5():591-5. PubMed ID: 12101743
[No Abstract] [Full Text] [Related]
4. Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract.
Dodd PM; McCaffrey JA; Hilton S; Mazumdar M; Herr H; Kelly WK; Icasiano E; Boyle MG; Bajorin DF
J Clin Oncol; 2000 Feb; 18(4):840-6. PubMed ID: 10673526
[TBL] [Abstract][Full Text] [Related]
5. ["Second line" polychemotherapy in metastatic urothelial cancer of the renal pelvis. Persisting partial remission by 18 treatment cycles of gemcitabine/paclitaxel after 24 treatment cycles gemcitabine/cisplatin "stable disease"].
Bannowsky A; Wefer B; Naumann M; Hamann M; Hautmann S; Jünemann KP
Urologe A; 2005 Aug; 44(8):915-7. PubMed ID: 15942775
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of metastatic urothelial carcinoma arising in a transplanted renal allograft with paclitaxel, cisplatin, and gemcitabine combination therapy: a case report.
Kojima Y; Takahi Y; Ichimaru N; Okumi M; Takahara S; Nonomura N
BMC Res Notes; 2015 Feb; 8():25. PubMed ID: 25648269
[TBL] [Abstract][Full Text] [Related]
7. [Case report of a patient with advanced pelvic and ureteral cancer whose primary lesion could be enucleated after cytoreduction by modified CAP regimen].
Mikata N; Imao S; Katoh A; Horiuti D; Tanaka Y; Sasaki H; Hamasima T
Gan No Rinsho; 1989 Dec; 35(15):1807-11. PubMed ID: 2481751
[TBL] [Abstract][Full Text] [Related]
8. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
9. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
Al-Husaini H; Soudy H; Darwish A; Ahmed M; Eltigani A; Edesa W; Elhassan T; Omar A; Elghamry W; Al-Hashem H; Al-Hayli S; Madkhali I; Ahmad S; Al-Badawi IA
Clin Transl Oncol; 2015 May; 17(5):409-15. PubMed ID: 25398721
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine, paclitaxel, and cisplatin as combined adjuvant approach in transitional cell carcinoma of the urothelium.
Ecke TD; Gerullis H; Bartel P; Koch S; Ruttloff J
Minerva Urol Nefrol; 2009 Sep; 61(3):249-56. PubMed ID: 19773726
[TBL] [Abstract][Full Text] [Related]
11. Exploring sequenced chemotherapy regimens in the treatment of transitional cell carcinoma of the urothelial tract.
Bajorin DF
Eur J Cancer; 2000 Jul; 36 Suppl 2():26-9. PubMed ID: 10908845
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
Liao RS; Gupta M; Schwen ZR; Patel HD; Kates M; Johnson MH; Hahn NM; McConkey D; Bivalacqua TJ; Pierorazio PM
J Urol; 2018 Jul; 200(1):68-73. PubMed ID: 29307680
[TBL] [Abstract][Full Text] [Related]
13. Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.
Hosogoe S; Hatakeyama S; Kusaka A; Hamano I; Iwamura H; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ohyama C
Eur Urol Focus; 2018 Dec; 4(6):946-953. PubMed ID: 28753881
[TBL] [Abstract][Full Text] [Related]
14. [Successful salvage chemotherapy with gemcitabine, etoposide and cisplatin for metastatic ureteral cancer: a case report].
Tsukamoto T; Yonese J; Ishii N; Maezawa T; Fukui I
Hinyokika Kiyo; 2002 Jul; 48(7):427-30. PubMed ID: 12229181
[TBL] [Abstract][Full Text] [Related]
15. Enterocolitis related to chemotherapy with gemcitabine and cisplatin in patient with transitional cell carcinoma of ureter.
Yang YJ; Lim JS; Lee HJ
Eur J Cancer Care (Engl); 2009 Nov; 18(6):657-8. PubMed ID: 19686356
[No Abstract] [Full Text] [Related]
16. The renal safety and efficacy of combined gemcitabine plus cisplatin and gemcitabine plus carboplatin chemotherapy in Chinese patients with a solitary kidney after nephroureterectomy.
Sun P; Xue C; Li LR; Shao C; An X; Thomas R; Yang W; Deng YF; Jiang WQ; Shi YX
Cancer Chemother Pharmacol; 2017 Jul; 80(1):37-44. PubMed ID: 28534209
[TBL] [Abstract][Full Text] [Related]
17. Current and future perspectives in advanced bladder cancer: is there a new standard?
von der Maase H
Semin Oncol; 2002 Feb; 29(1 Suppl 3):3-14. PubMed ID: 11894002
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of chemo-refractory pulmonary metastases of renal pelvic cancer by second-line chemotherapy including gemcitabine followed by salvage surgery.
Tadokoro M; Yonese J; Tsukamoto T; Okubo Y; Hanada E; Satoh Y; Nakagawa K; Ishikawa Y; Fukui I
Int J Urol; 2005 Feb; 12(2):208-10. PubMed ID: 15733118
[TBL] [Abstract][Full Text] [Related]
19. [Adjuvant chemotherapy with MVP-CAB (methotrexate, vincristine, cisplatinum, cyclophosphamide, adriamycin and bleomycin) for epithelial tumors of the upper urinary tract].
Fujii A; Oka N; Murata Y; Higuchi A; Itoh N; Ishikawa J; Tanaka H
Nihon Hinyokika Gakkai Zasshi; 1992 Oct; 83(10):1609-14. PubMed ID: 1279258
[TBL] [Abstract][Full Text] [Related]
20. Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy.
Ikeda M; Matsumoto K; Tabata K; Minamida S; Fujita T; Satoh T; Iwamura M; Baba S
Jpn J Clin Oncol; 2011 Oct; 41(10):1214-20. PubMed ID: 21903707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
